←Back to Expert Scholars
Translational Medicine / 转化医学Aplastic Anemia
Phillip Scheinberg
MD
🏢Hospital A Beneficencia Portuguesa de Sao Paulo🌐Brazil
Head of Hematology
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Phillip Scheinberg has led trials establishing eltrombopag plus immunosuppression as standard first line therapy for severe aplastic anemia. He has characterized long term outcomes and risk of clonal evolution in AA patients. He directs hematology research in Brazil with global collaborations.
Share:
🧪Research Fields 研究领域
aplastic anemia
immunosuppression
eltrombopag
bone marrow failure
international trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Phillip Scheinberg 的研究动态
Follow Phillip Scheinberg's research updates
留下邮箱，当我们发布与 Phillip Scheinberg（Hospital A Beneficencia Portuguesa de Sao Paulo）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment